OANN – Johnson & Johnson said it represents a “25% increase in investment compared to the previous four years” and builds on their “already elevated U.S. investment levels resulting from the passage of the 2017 Tax Cuts & Jobs Act” under President Donald Trump’s leadership.
Our increased U.S. investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add U.S.-based jobs but manufacture cutting edge medicines to treat patients in America and around the world,” Chairman and CEO Joaquin Duato said in a statement.
